Communicating the Good, Bad & Ugly for CMOs and R&D Leaders in Biotech

This discussion provides helpful approaches for Chief Medical Officers (CMOs) and other R&D leadership in biotech on how to communicate effectively in times of good, bad or unexpected news. Also discussed in this program are factors to evaluate for the discontinuation of a program. Dr Mark Weinberg, Chief Medical Officer and Managing Director of Halloran Consulting Group will be joined by Dr Lee Allen, CMO, Argos Therapeutics to discuss strategic communication strategies CMOs/R&D leadership can utilize to effectively deliver unexpected or difficult news.

 More specifically:

• How do you communicate successfully?
• How does a CMO manage an unexpected realization?
• Tips on being an advocate and skeptic for your programs
• Flexibility and decision making with data
• Scenario planning
• Tips on communicating to the public
• Evaluating factors for discontinuing a program
• Rationalizing your portfolio? Who decides?

Guests:

Lee Allen, MD, PhD, CMO, Argos Therapeutics

Mark Weinberg, MD, MBA, CMO and Managing Director, Halloran Consulting Group

Producer:

Valerie Bowling,  Executive Director, PharmaTalk Radio & The Conference Forum

Recommended Conference: The CMO and R&D Biotech Leadership Summit, Nov 14-15 in San Francisco. For more info:

http://theconferenceforum.org/conferences/rdbiotechleadershipsummit/overview/